| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 46.09× | 46.09× | 49.60× | 55.72× | 61.08× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.25× | 1.53× | 1.60× | 1.54× | 2.29× | ||
| 0.67× | 0.67× | 0.66× | 0.70× | 0.75× | ||
| 1.10× | 1.10× | 1.12× | 0.88× | 1.06× | ||
| 0.82× | 0.82× | 0.88× | 0.73× | 0.90× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 61.08 | 55.72 | 49.60 | 46.09 | 46.09 | |
| Working Capital Turnover | 2.29 | 1.54 | 1.60 | 1.53 | 1.25 | |
| Asset Turnover | 0.75 | 0.70 | 0.66 | 0.67 | 0.67 | |
| Cash Conversion (CFO/Net Income) | 1.06 | 0.88 | 1.12 | 1.10 | 1.10 | |
| CFO/EBITDA | 0.90 | 0.73 | 0.88 | 0.82 | 0.82 |